OBJECTIVE: To investigate whether prohibitin (PHB) is a target gene in adipocyte differentiation and modulates insulin-induced adipocyte differentiation. DESIGN: 3T3-L1 preadipocyte overexpressing wild-type PHB and PHB mutant (lacking tyrosine-114 phosphorylation site) with or without insulin. RESULTS: The treatment of 3T3-L1 fibroblasts with insulin or peroxisome proliferator-activated receptor-g agonist resulted in an upregulation of PHB in a dose-and time-dependent manner. An analysis of the PHB promoter sequence revealed the presence of putative insulin-response elements and CCAAT/enhancer-binding protein transcription elements within B1 kb upstream of the translation initiation site. The functional relevance of these sites was determined using reporter gene assay. Surprisingly, PHB was also found to be regulated by leptin. Furthermore, the overexpression of PHB in 3T3-L1 fibroblasts was sufficient to induce adipogenesis. CONCLUSION: In summary, we have identified PHB as an important protein in adipocyte differentiation.
INTRODUCTION
Obesity is a growing concern worldwide. It is a risk factor in a number of chronic diseases that afflicts our society, including type 2 diabetes, cardiovascular disease and cancer. 1 In recent years, numerous studies have focused on identifying the mechanism of the development of obesity, which is a process of increasing the number of adipocytes (hyperplasia), the enrichment of adipocytes with each carrying greater amount of fat (hypertrophy) or both. 1, 2 The ability to regulate the number of adipocytes and/or size of adipocytes is a key in the prevention and treatment of obesity and also in the origin of chronic diseases.
Insulin is a potent adipogenic hormone. The adipogenic actions of insulin are mediated by insulin's receptor tyrosine kinase signaling. 3 Two major signaling pathways are located downstream of the insulin receptor: the phosphatidylinositol 3 kinase/protein kinase B (PI3K/Akt) and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathways. 4, 5 The mechanisms by which insulin regulate adipogenesis are complex and involves the upregulation of transcription factors and subsequently various target genes critical for adipogenesis. 6, 7 CCAAT/enhancer-binding protein (C/EBP)b and C/EBPd are the first transcription factors induced at the onset of adipocyte differentiation; they are therefore postulated to be involved in directing the differentiation process. 8 The activity of C/EBPb and C/EBPd mediate the expression of C/EBPa, which increases from undetectable levels in preadipocytes to detectable levels after initiation of the differentiation process. 9, 10 Furthermore, C/EBPb and C/EBPd are thought to mediate the expression of peroxisome proliferator-activated receptor g (PPARg). 11, 12 Once activated, C/EBPa and PPARg cross-regulate each other to maintain their gene expression. 13 C/EBPa and PPARg alone or in co-operation with each other induce the transcription of a number of adipocyte genes encoding proteins and enzymes involved in creating and maintaining the adipocyte phenotype. 14, 15 Prohibitin (PHB, also known as PHB1) is an evolutionarily conserved protein, which is predominantly localized to the mitochondria, an important cell organelle in adipogenesis. 16 --18 Furthermore, PHB gene has been mapped to the chromosome 17q12-q21 locus. 19 Locus 17q21 has been identified among chromosomal regions harboring genes influencing the propensity to store fat in the abdominal area in a genome-wide scan. 20 Moreover, PHB has been identified among proteins associated with lipid droplets from 3T3-L1 adipocytes, and siRNA-mediated knockdown of PHB in Caenorhabditis elegans results in significant reduction in intestinal fat content. 21, 22 Collectively, these evidences point toward a role of PHB in adipogenesis that has not been explored. Recently, we have reported that PHB modulates insulin signaling in a phosphorylation-dependent manner. 23, 24 In addition, we have shown that PHB interacts with pyruvate carboxylase (PC), 25 an important enzyme involved in de novo fatty acid synthesis and glyceroneogenesis. 26 Furthermore, PHB has been reported to be involved in Raf activation and to have an important role in MAPK/ERK signaling. 27 The PI3K/Akt and the MAPK/ERK signaling pathways are known to crosstalk with each other and have a critical role in adipocyte differentiation. 28 --30 Conceivably, the ability of PHB to modulate PI3K/Akt and MAPK/ ERK signaling may influence insulin's effect on adipogenesis. In this study, we examined whether PHB is involved in adipogenesis, and report a surprising finding that PHB is a target gene for insulin during adipogenesis and is involved in adipocyte homeostasis.
MATERIALS AND METHODS Reagents
Anti-PHB, anti-ERK pan, anti-phosphoERK (pERK), anti-CREB and -phospho-CREB antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). Antibody to PPARg was purchased from Santa Cruz Biotecnology Inc. (Santa Cruz, CA, USA). Insulin and all other reagents were obtained from Sigma-Aldrich (Oakville, ON, Canada) unless otherwise stated. 3T3-L1 fibroblasts were obtained from the American Type Culture Collection (Manassas, VA, USA) and cell culture reagents were from Invitrogen (Burlington, ON, Canada). Phospho-Akt kit was obtained from Cell Signaling Technology.
Site-directed mutagenesis PHB mutant lacking Tyr114 phosphorylation site (Tyr114Phe, mPHB) and PHB reporter gene construct lacking insulin-response element (IRE) at position À1031/À1025 and À1010/À1004 were generated using site-directed mutagenesis kit (Stratagene, Santa Clara, CA, USA), as described earlier. 23, 31 The following primers were used to generate IRE mutant (mIRE) reporter constructs: À1031/À1025 mutant, forward 5 0 -C GTCTCTACAAAAATAAAAAATTAGCCGGGTGTCCCCCCGCATGCCTGTAATCTCA GCTATTCTG-3 0 reverse 5 0 -CAGAATAGCTGAGATTACAGGCATGCGGGGGGA CACCCGGCTAATTTTTTATTTTTGTAGAGACG-3 0 and À1010/À1004 mutant,
0 . Authenticity of all the constructs was confirmed by DNA sequencing. Transfections were performed using FuGene HD Transfection Reagents (Roche, Laval, QC, Canada), as per manufacturer's protocol.
Cell culture and transfection 3T3-L1 fibroblasts were grown to 70% confluence in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 50 mg ml À1 gentamycin, 0.5 mM glutamine and 0.5 mg ml À1 fungizone. Differentiation was initiated by addition of adipocyte-induction cocktail containing 40 mg ml À1 isobutylmethylxanthine, 400 ng ml À1 dexamethasone and 0.5 mg ml À1 insulin for 48 h. After 2 days, induction cocktail was replaced with 1 mM insulin and was re-fed every 2 days. Differentiation of fibroblasts into mature adipocytes was confirmed by Oil Red O staining. 32 
Luciferase reporter assays
The cloning of PHB promoter-luciferase construct (À1054/ þ 138-PHB-Luc) and its various deletion constructs have been described before.
33 3T3-L1 cells were co-transfected with full length and deletion constructs of PHB promoter and Renilla-luciferase vector (pRL-CMV, Promega, Madison, WI, USA), as internal control. After transfection for 48 h, cells were serum starved for 4 h and then incubated in the presence and absence of troglitazone (TZD) or insulin. Afterwards cells were lysed using passive lysis buffer, and luciferase activity was measured using Dual-Luciferase Reporter Assay system kit (Promega) and by using Luminometer (Lumat LB 9507). Relative luciferase activity was calculated by normalizing the firefly luciferase activity to enilla luciferase activity of the pRL-CMV vector.
Real-time PCR
Total RNA was extracted from the 3T3-L1 cells transfected with vector, wild-type PHB and mutant-PHB (mPHB, lacking Tyr114 phosphorylation site) constructs using RNA easy plus mini kit (Qiagen, Toronto, ON, Canada). The cDNA was synthesized from total RNA (1 mg) using reverse transcriptase and oligo-deoxythymidine primers (Invitrogen, Carlsbad, CA, USA). The following primers were used for amplification of cDNA using real- 
Western immunoblotting
Preadipocytes and adipocytes were harvested from the culture plates with cell lysis buffer (1 Â PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate and 0.1% SDS) containing freshly added protease inhibitor cocktail. 24, 34 Twenty-five micrograms of protein per lane and known molecular weight markers from Bio-Rad (Mississauga, ON, USA) were separated by SDS-PAGE. Proteins were electrophoretically transferred onto nitrocellulose membranes and incubated overnight at 4 1C with protein/phosphoproteinspecific antibody in blocking solution (5% non-fat milk in TBS). After washing, membranes were incubated with the HRP-conjugated respective secondary antibody (1:1000 dilutions with 1% non-fat milk in TBS) for 1 h at room temperature and then washed three times with TBS buffer containing 0.1% Tween 20 for 15 min at room temperature with shaking. Immunodetection analyses were accomplished using the Enhance Chemiluminescence Kit (Roche).
Oil Red O staining 3T3-L1 adipocytes were stained with Oil Red O, as described by Ramírez-Zacarías et al. 32 The 3T3-L1 cells were fixed in 10% formalin for 90 min. After washing thoroughly with distilled water, cells were incubated with a working solution of Oil Red O for 3 h. The staining of lipid droplets in 3T3-L1 preadipocyte and adipocyte cells was quantified using Olympus BX40 microscope and Lumenera Infinity software (Lumenera Corporation, Ottawa, ON, Canada).
Statistical analysis
Experimental results are shown as means ± s.e.m. One-way ANOVA with Dunnett's test was used for multiple comparisons. P-values o0.05 were considered significantly different.
RESULTS

PHB modulates insulin-induced adipogenesis
Insulin's effect on adipogenesis is mediated through both the PI3K/Akt and the MAPK/ERK signaling pathways; 35 and PHB has been reported to have a modulatory effect on these pathways. 24, 27, 36 Furthermore, we have shown that phosphorylation of PHB at tyrosine114 (Tyr114) residue attenuates PI3K/Akt signaling. 23, 24 In this study, we tested whether forced expression of PHB would change insulin-induced adipogenesis. To determine this, we used 3T3-L1 fibroblasts as a model cell line. The 3T3-L1 cell is a well characterized model for adipocyte differentiation and lipid metabolism. This model shares similar morphology, gene expression and metabolism with adipocytes in vivo.
10,22 3T3-L1 cells were transfected with wild-type PHB and mutant Tyr114Phe-PHB (mPHB) constructs and cultured in the presence of an induction cocktail for 48 h. After 2 days, the cells were cultured with and without insulin instead of the induction cocktail. Insulin alone has been used previously to maintain adipocyte differentiation. 15, 35 As expected, insulin treatment maintained adipocyte differentiation in the empty vector-transfected control group, which was significantly reduced in cells overexpressing wild-type PHB ( Figure 1a) . However, only a modest inhibition of adipocyte differentiation was observed in cells overexpressing mPHB, suggesting a role for Tyr114 phosphorylation in this process ( Figure 1a) . Surprisingly, a significant increase in adipocyte differentiation was observed without insulin treatment in cells overexpressing wild-type PHB in comparison with vector control group ( Figure 1a) . Similarly, mPHB was also able to induce adipocyte differentiation without insulin, however, to a lesser extent than wild-type PHB ( Figure 1a) . A differential effect of PHB overexpression on the morphological differentiation of adipocytes with and without insulin, as determined by oil red O staining, would mean that PHB modulates adipocyte differentiation in more than one way. Furthermore, this would imply that insulin and PHB keep checks and balances on each other to maintain adipose tissue homeostasis under normal condition.
The PHB-induced adipocyte differentiation was further confirmed by analyzing mRNA expression levels of adipocyte marker genes aP2, C/EBPa and PPARg using real-time PCR (Figure 1b) . The mRNA expression levels of all the three marker genes were significantly upregulated in cells overexpressing wild-type PHB in comparison with empty vector transfected control group (Figure 1b) . No significant change in mRNA expression levels of aP2 and C/EBPa were found in cells overexpressing mPHB in comparison with vector control group; however, a significant increase in PPARg mRNA expression was observed in mPHB overexpressing cells (Figure 1b) . Taken together, these data suggest that PHB has a role in adipocyte differentiation and may represent an important target gene during the differentiation process.
PHB overexpression upregulates MAPK/ERK signaling To further explore the underlying mechanism involved in PHBinduced adipocyte differentiation, we examined the effect of PHB overexpression on MAPK/ERK signaling. A significant upregulation of phospho-ERK1/2 (pERK1/2) was observed in 3T3-L1 cells overexpressing PHB without insulin in comparison with insulin treated cells (Figure 2a) . However, this difference was not apparent in cells overexpressing mPHB lacking Tyr114 phosphorylation site (Figure 2a) . A similar change was also found in pCREB level (Figure 2b ), a downstream signaling intermediate of MAPK/ ERK pathway. In addition, an inverse relationship was observed between pAkt and pERK1/2 levels in cells overexpressing PHB (Figures 2a and c) . Most importantly, similar to changes in pERK1/2 and pCREB levels, a parallel change in C/EBPa, C/EBPb and PPARg protein levels were found in cells overexpressing PHB (Figure 2d ). Collectively, these data suggest a role for MAPK/ERK signaling in PHB-induced adipogenesis and a role for PHB in the crosstalk between PI3K/Akt and MAPK/ERK signaling (during the differentiation process).
Insulin upregulates PHB A significant upregulation of PHB protein in response to insulin ( Figure 1a ) prompted us to validate whether PHB is an insulinregulated protein.
To determine this, 3T3-L1 cells were treated with insulin, and cell lysates were processed for immunoblot analysis using anti-PHB antibody. Indeed, an increase in PHB protein level was found in a dose-and time-dependent manner confirming a role of insulin in the regulation of PHB protein ( Figure 3 ). In addition, a decrease in PHB protein level was observed in control groups (without insulin treatment) as cells progressed toward confluence. Insulin-induced transcription factor PPARg is known to be involved in the regulation of a wide range of genes involved in adipogenesis; 37 therefore, we tested whether PPARg is also involved in insulin-induced upregulation of PHB. Treatment of 3T3-L1 cells with a potent and selective PPARg agonist TZD led to a significant increase in PHB protein level in a dose-and time-dependent manner ( Figure 3 ). Taken together, these data suggest that insulin and PPARg upregulates PHB in 3T3-L1 cells.
PHB promoter contains multiple IRE and C/EBP regulatory elements An enhanced adipocyte differentiation in 3T3-L1 cells overexpressing PHB and upregulation of PHB by insulin and PPARg agonist impelled us to analyze the promoter sequence of PHB (GenBank accession number DQ406856) for putative IRE, C/EBP and PPAR-binding elements. The analysis of PHB promoter sequence by Transcription Element Search System (TESS; http:// www.cbil.upenn.edu/cgi-bin/tess/tess) revealed that PHB promoter indeed contains multiple C/EBP-a, -b and -d-binding elements present within B500 nucleotides from translation initiation site ( Figure 4 ). In addition, putative IREs were also predicted toward the distal end within À1054 to À550 nucleotides ( Figure 4) . No canonical PPARg-binding element was found within PHB promoter region À1054/ þ 1 with this server.
Putative IREs in PHB promoter are functional To further explore whether putative regulatory elements in PHB promoter are functional, we used a luciferase reporter gene assay. 3T3-L1 cells were co-transfected with the Luc-PHB reporter construct and pRL-CMV (Renilla luciferase), as an internal control using FuGene transfection reagent. Treatment of 3T3-L1 cells with insulin and TZD leads to a significant increase in luciferase activity in a dose-dependent manner, suggesting that putative regulatory elements in PHB promoter are functional (Figures 5a and b) . The stimulatory effect of TZD was suppressed in the presence of GW9662, a PPARg-specific antagonist, indicating that the action of TZD was mediated through PPARg ( Figure 5b ). As a canonical PPAR-binding element was not predicted in the PHB promoter (used in the reporter gene assay) by TESS server, this would imply that PPARg action was either mediated through a non-canonicalbinding element or through a composite element indirectly regulated by PPARg. Furthermore, to determine the regulatory elements necessary for basal PHB promoter activity, we used deletion constructs developed through internal restriction enzyme digestion within the full-length PHB promoter-luciferase construct (Figures 5c). The analysis of the deletion constructs revealed two regions within the full length promoter; nucleotides À1054 to À949 and À189 to À35 responsible for insulin and PPARg response, respectively (Figures 5c and d) . The first region (nucleotides À1054 to À949) contains putative IRE similar to IRE present in amylase and PEPCK promoters, 38, 39 and the second region (nucleotides À189 to À35) contains multiple C/EBPs binding elements (Figure 4) . The functional importance of putative IRE was further confirmed using mutant constructs lacking IRE. Substitution of IRE present between À1031 and À1025 nucleotides resulted in a B37% loss in promoter activity in response to insulin, whereas substitution of IRE present between À1010 and À1004 nucleotides leads to B67% loss in promoter activity under similar condition (Figure 5d ). Taken together, these data strongly suggest that PHB is a typical target gene in adipogenesis.
PHB is downregulated in adipose tissues of ob/ob mice As our data suggests an important role for PHB in adipogenesis, we examined whether PHB protein level is altered in the adipose tissue of leptin-deficient ob/ob mice. Western blot analysis revealed that PHB is significantly downregulated in the adipose tissue of ob/ob mice in comparison with wild-type mice, suggesting a role for leptin in the regulation of PHB protein level in adipose tissue (Figure 6a) . Leptin is an adipocyte-derived circulating hormone that acts as an adiposity signal and functions both centrally and peripherally to induce the loss of adipose tissue. 40 Furthermore, leptin has been shown to regulate a number of proteins in adipose tissue. 40 To further confirm that low PHB level is directly associated with the lack of leptin in ob/ob mice, 3T3-L1 adipocytes were treated with leptin. Post-treatment proteins were harvested and analyzed by immunoblotting using anti-PHB antibody. Western blot analysis revealed that leptin indeed upregulated PHB, confirming a role of leptin in the regulation of PHB in adipocytes (Figure 6b ). It would be interesting to know whether reduced PHB level in adipose tissue of ob/ob mice contribute to the impaired adipose tissue homeostasis in these mice.
DISCUSSION
Obesity is one of the major health concerns in many parts of the world. At the cellular level, obesity is characterized by both increase in number and size of adipocytes. 41 New adipocytes largely arise by differentiation of preadipocytes, which is a highly regulated process. 42, 43 Insulin, within its physiologic range, is known to induce adipocyte differentiation and lipogenesis and has an important role in adipose tissue homeostasis. 6, 14, 44 However, the precise mechanism connecting insulin signaling with the intrinsic regulatory mechanisms of adipogenesis remains obscure. Understanding the role of insulin is of special importance because of the potential influence of in vivo hyperinsulinemia on the development of obesity. 35 Hyperinsulinemia is well known to be intimately associated with insulin resistance, which is characterized by impairment of PI3K/Akt signaling. 45 A common occurrence of obesity in patients with insulin resistance would mean that hyperinsulinemia may contribute to adipogenesis in multiple ways. It is possible that insulin resistance leads to the impairment of regulatory mechanisms and/or factors involved in the maintenance of adipocyte homeostasis. In this context it should be noted that the PI3K/Akt signaling and the MAPK/ERK signaling, which represents two arms of insulin's adipogenic signal, also crosstalk with each other and are known to be selectively impaired under insulin resistance condition, especially PI3K/Akt signaling. 3, 28, 30 Herein, we report that treatment of 3T3-L1 cells with insulin or PPARg agonist leads to upregulation of PHB during adipogenesis. Interestingly, overexpression of PHB was found to inhibit insulin-induced adipogenesis, whereas in the absence of insulin PHB facilitates adipogenesis through upregulation of MAPK/ERK signaling. Furthermore, a significant upregulation of phospho-ERK1/2 (pERK1/2) was observed in 3T3-L1 cells overexpressing PHB without insulin in comparison with insulin-treated cells. In addition, an inverse relationship was observed between pAkt and pERK1/2 levels in cells overexpressing PHB. Our findings of the differential regulation of MAPK/ERK pathway by PHB in relation to insulin signaling may be one of the underlying mechanisms involved in enhanced adipogenesis under insulin resistance condition. In addition, our data of upregulation of PHB by PPARg agonist would indicate that PHB may contribute to lipid partitioning and weight gain in patients on thiazolidinedione therapy. The data presented here strongly suggests that PHB is an important target gene during adipocyte differentiation. The deletion of IREs and C/EBPs binding elements in PHB promoter resulted in a significant decrease in reporter gene activity in response to insulin and PPARg agonist, respectively. On the other hand, the overexpression of PHB alone was found to induce adipogenesis as determined by the morphological differentiation and the expression of adipocyte markers genes. A number of proteins that are known to have an important role in adipogenesis are also required for mitochondrial biogenesis, suggesting a link between these two processes. 18, 46 In addition to adipogenesis, mitochondria are also central to iron homeostasis and oxidative metabolism. 47, 48 However, the role of irondependent oxidative metabolism in protecting the oxidizable lipid substrates contained in mature adipocyte is not understood. A correlation between the adipocyte differentiation and an increase in iron-binding protein, ferritin, has been observed earlier. 48 It has been suggested that accumulation of iron-binding protein may limit the toxicity of iron in adipose tissue, thus exerting an anti-oxidant effect. 48 In this context it is important to note that PHB has been reported to provide protection against oxidative damage, and we have reported that PHB functions as an iron-binding protein and is involved in mitochondrial iron homeostasis. 47, 49 Furthermore, the downregulation of PHB protein level in adipose tissues from ob/ob mice and upregulation of PHB in response to leptin in 3T3-L1 adipocytes further support a role of PHB in adipose tissue homeostasis. Upregulation of PHB by insulin and an inhibitory effect of PHB overexpression on insulin-induced adipogenesis may represent a negative feedback relationship between insulin and PHB to maintain each other's function, and subsequently adipose tissue homeostasis under normal condition. Enhanced adipogenesis under hyperinsulinemia/insulin resistance or under leptin resistance condition may be due to impaired negative feedback regulation to maintain the PHB level and function. Interestingly, the acute phase cytokine IL-6 that is known to induce insulin resistance also upregulates PHB through IL-6 response element present in PHB promoter. 33 An upregulation of the PHB protein by IL-6 under insulin resistance may contribute to enhanced adipogenesis and impaired adipose tissue homeostasis. Our finding of PHB, an important protein in mitochondrial biogenesis and function, as an overlapping target of various factors involved in adipose tissue homeostasis is not surprising and consistent with other reports. 17, 18 The development and maintenance of adipocyte phenotype requires a major shift in metabolic pathways that involves concerted efforts toward fatty acid synthesis and glyceroneogenesis. The enzyme PC is present at a very unique position in metabolic pathways that has a critical role in providing substrates required for de novo triglycerides synthesis. 26, 34 It is not unexpected that PC is upregulated B20-fold during adipocyte differentiation. 50 In addition, PC has an important role in the TCA cycle by regeneration of oxaloacetate, a driving force not only for pyruvate and fatty acid oxidation but also for glyceroneogenesis. 26, 50 Previously, we have reported that PHB interacts with PC and inhibits insulin-induced glucose and fatty acid oxidation in adipose tissues. 25 However, the relevance of PHB and PC interaction in fatty acid synthesis and glyceroneogenesis remain to be determined. Enhanced lipogenesis in PHB overexpressing 3T3-L1 adipocytes would indicate that a metabolic shift may underlie the molecular mechanism involved in PHB's role in the adipogenesis mediated through PC, in addition to the modulatory effect of PHB on insulin signaling.
Moreover, our findings of increased adipogenesis in 3T3-L1 cells overexpressing PHB, and a recent report of diminished intestinal fat content in C. elegans after siRNA-mediated knockdown of PHB, and a significant increase in fat content in dauer formation-2 (daf-2, insulin/IGF signaling equivalent in C. elegans) mutant with normal PHB, 21 are in agreement with our proposed mechanism of action for PHB in adipocyte homeostasis ( Figure 7 ). As PHB is also important for mitochondrial structure and function, collectively these findings would suggest a critical role for PHB in the functional adjustment of mitochondria during adipogenesis (Figure 7) .
In summary, we have provided convincing evidence, suggesting PHB as an important protein in adipocyte biology. Further studies to identify the mechanisms involved in PHB's role in adipogenesis and factors regulating PHB will hopefully provide information for the development of strategies to reduce the enhanced adipogenesis associated with obesity, which leads to debilitating disorders, including type 2 diabetes and cardiovascular diseases. The continued research will determine if interfering with the action of PHB has preventive or therapeutic applications in obesity.
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pY pT Figure 7 . Schematic diagram showing the interconnection of PHB with various cellular factors known to be involved in adipogenesis. We propose that PHB contributes to adipose tissue homeostasis (i) by regulating adipocyte differentiation through modulating insulin signaling and mitochondrial biogenesis and (ii) by regulating lipogenesis through modulating pyruvate carboxylase and mitochondrial function. Furthermore, we propose that phosphorylation of PHB has a regulatory role in these processes. Orange dash arrow---negative or positive effect (in a phosphorylation-dependent manner); curved arrow---crosstalk; dash and dot purple arrow---modulatory effect, which may be associated with metabolic switch toward lipogenesis; solid green arrow---positive effect. pT, phosphorylated-threonine; pY, phosphorylated-tyrosine.
